DID NOT SEE THIS ONE TILL NOW.
BUT THERE MIGHT BE SOME BEEF LEFT.MHTX - LAST PRICE .135¢ (+107.69%)
NEW YORK, Feb 03, 2004 /PRNewswire via COMTEX/ --Manhattan Scientifics, Inc.(MHTX) announced today that it has licensed its mid-range (NovArs) fuel celltechnology to a Singapore company with manufacturing in China. The contractgives the licensee non-exclusive rights to produce and sell fuel cell enginesbased on the NovArs technology owned by Manhattan Scientifics. The agreementinvolves an upfront payment, royalty and other forms of consideration.
Manhattan Scientifics' COO Jack Harrod said, "This is a positive step inour efforts to provide low-cost fuel cells systems to Chinese, Asian and otherworldwide markets. We believe this relationship provides a basis for buildingfuture shareholder value." The technology was licensed last May to BallardPower Systems of Canada on a non-exclusive basis.
About Manhattan Scientifics
Manhattan Scientifics, Inc. (www.mhtx.com) is a technology developmentcompany working in the fields of alternative energy and computer touch hapticstechnology. The company's facilities are located in Los Alamos andAlbuquerque, New Mexico and New York City. Copies of Manhattan Scientifics'press releases, current quotes, stock charts and other information forinvestors may be found on the websites www.hawkassociates.com andwww.hawkmicrcocaps.com.
The foregoing press release contains forward-looking statements (includingexpectation of future events), which are subject to risks, and uncertainty,which may be beyond the company's control. Actual results could differmaterially for many reasons including but not limited to completion of R&D andsuccessful commercialization of products/services, patent completion,prosecution and defense against well-capitalized competitors. These areserious risks and there is no assurance that our forward-looking statementswill occur or prove to be accurate.
Executive Contact:
Marvin Maslow, CEO, Manhattan Scientifics (917) 923-3300.
Email: maslow@ix.netcom.com
Investor Relations Contact:
Frank Hawkins, (Hawk Associates) (305) 852-2383
Email: Info@hawkassociates.com
SOURCE Manhattan Scientifics
Marvin Maslow, CEO, Manhattan Scientifics, +1-917-923-3300, or
maslow@ix.netcom.com; or Investor Relations, Frank Hawkins, Hawk Associates,
+1-305-852-2383, or email, Info@hawkassociates.com, for Manhattan Scientifics http://www.prnewswire.com
Copyright (C) 2004 PR Newswire. All rights reserved.NewsProvided by COMTEX, http://www.comtex.com/